Novo Nordisk Investigational Site

Danville, Pennsylvania 17822-2111

0 studies enrolling now · 6 studies all time

What they study most

Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hepatobiliary Disorders, Non-alcoholic Steatohepatitis

Studies at this site

• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. — Completed
• A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events — Completed
• Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes — Completed
• The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes — Completed
• Use of Activated Recombinant Human Factor VII in Cardiac Surgery — Stopped early
• Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population — Completed